These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27800156)

  • 1. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?
    Mei KL; Batsis JA; Mills JB; Holubar SD
    Perioper Med (Lond); 2016; 5():30. PubMed ID: 27800156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
    Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.
    Rodrigues V; Landi F; Castro S; Mast R; Rodríguez N; Gantxegi A; Pradell J; López-Cano M; Armengol M
    J Gastrointest Surg; 2021 Jun; 25(6):1388-1403. PubMed ID: 32661833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sarcopenia on the surgical outcomes in patients with hepatolithiasis: A multicenter 10-year experience.
    Wang T; Chen X; Liao C; Wang D; Huang L; Li G; Chen J; Lin C; Wang L; Pan J; Zhang C; Zhou S; Qiu F; Wang Y; Zhang Z; Chen Y; Zheng X; Tian Y; Chen S
    Surgery; 2022 Dec; 172(6):1712-1721. PubMed ID: 36280506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Sarcopenia and Sarcopenic Obesity in an Academic Total Joint Arthroplasty Practice.
    DeMik DE; Marinier MC; Glass NA; Elkins JM
    Arthroplast Today; 2022 Aug; 16():124-129. PubMed ID: 35677943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection.
    Lodewick TM; Roeth AA; Olde Damink SW; Alizai PH; van Dam RM; Gassler N; Schneider M; Dello SA; Schmeding M; Dejong CH; Neumann UP
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):155-63. PubMed ID: 26136191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
    Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
    Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
    Fehrenbach U; Wuensch T; Gabriel P; Segger L; Yamaguchi T; Auer TA; Beetz NL; Denecke C; Kröll D; Raakow J; Knitter S; Chopra S; Thuss-Patience P; Pratschke J; Hamm B; Biebl M; Geisel D
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric Surgery Outcomes in Sarcopenic Obesity.
    Mastino D; Robert M; Betry C; Laville M; Gouillat C; Disse E
    Obes Surg; 2016 Oct; 26(10):2355-62. PubMed ID: 26926186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
    Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Consequences of Sarcopenic Obesity: A Narrative Review.
    Roh E; Choi KM
    Front Endocrinol (Lausanne); 2020; 11():332. PubMed ID: 32508753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Sarcopenia, Sarcopenic Obesity, and Changes in Physical Function in Surgical Oncology Patients Referred for Prehabilitation.
    Ngo-Huang A; Herbert A; Fontillas RC; Parker NH; Asumbrado R; Garg N; Dibaj S; Liu DD; Ng AH; Guo Y; Shin KY; Katz MHG; Bruera E
    Integr Cancer Ther; 2021; 20():15347354211000118. PubMed ID: 33829906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity.
    Öztürk ZA; Türkbeyler İH; Abiyev A; Kul S; Edizer B; Yakaryılmaz FD; Soylu G
    Intern Med J; 2018 Aug; 48(8):973-981. PubMed ID: 29665258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
    Baracos VE; Arribas L
    Ann Oncol; 2018 Feb; 29(suppl_2):ii1-ii9. PubMed ID: 29506228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of classic and specific bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity.
    Marini E; Buffa R; Saragat B; Coin A; Toffanello ED; Berton L; Manzato E; Sergi G
    Clin Interv Aging; 2012; 7():585-91. PubMed ID: 23269864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.
    Mintziras I; Miligkos M; Wächter S; Manoharan J; Maurer E; Bartsch DK
    Int J Surg; 2018 Nov; 59():19-26. PubMed ID: 30266663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.